JP2013532129A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532129A5 JP2013532129A5 JP2013510331A JP2013510331A JP2013532129A5 JP 2013532129 A5 JP2013532129 A5 JP 2013532129A5 JP 2013510331 A JP2013510331 A JP 2013510331A JP 2013510331 A JP2013510331 A JP 2013510331A JP 2013532129 A5 JP2013532129 A5 JP 2013532129A5
- Authority
- JP
- Japan
- Prior art keywords
- sflt
- pregnancy
- subject
- level
- apheresis treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33482410P | 2010-05-14 | 2010-05-14 | |
| US61/334,824 | 2010-05-14 | ||
| US34621610P | 2010-05-19 | 2010-05-19 | |
| US61/346,216 | 2010-05-19 | ||
| PCT/US2011/036409 WO2011143538A1 (en) | 2010-05-14 | 2011-05-13 | Extracorporeal devices and methods of treating complications of pregnancy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016030745A Division JP2016147065A (ja) | 2010-05-14 | 2016-02-22 | 妊娠合併症を治療するための体外デバイスおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532129A JP2013532129A (ja) | 2013-08-15 |
| JP2013532129A5 true JP2013532129A5 (https=) | 2014-05-15 |
| JP5959506B2 JP5959506B2 (ja) | 2016-08-02 |
Family
ID=44911968
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013510331A Active JP5959506B2 (ja) | 2010-05-14 | 2011-05-13 | 妊娠合併症を治療するための体外デバイスおよび方法 |
| JP2016030745A Pending JP2016147065A (ja) | 2010-05-14 | 2016-02-22 | 妊娠合併症を治療するための体外デバイスおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016030745A Pending JP2016147065A (ja) | 2010-05-14 | 2016-02-22 | 妊娠合併症を治療するための体外デバイスおよび方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8969322B2 (https=) |
| EP (3) | EP3248946B1 (https=) |
| JP (2) | JP5959506B2 (https=) |
| CN (1) | CN102884006B (https=) |
| AU (1) | AU2011252954B2 (https=) |
| CA (1) | CA2799227C (https=) |
| WO (1) | WO2011143538A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011252954B2 (en) | 2010-05-14 | 2015-04-16 | Beth Israel Deaconess Medical Center | Extracorporeal devices and methods of treating complications of pregnancy |
| US8979787B2 (en) * | 2011-01-20 | 2015-03-17 | Henry John Smith | Treatment of pre-eclampsia using targeted apheresis |
| MX2015010174A (es) * | 2013-02-08 | 2016-03-31 | Univ Iowa Res Found | Herramientas de diagnostico para predecir la presentacion de preeclampsia. |
| KR20160102440A (ko) * | 2013-12-27 | 2016-08-30 | 엘리아스 세라퓨틱스 인코포레이티드 | 혈장 분리 반출 장치 |
| EP3097422B1 (en) | 2014-01-24 | 2018-07-11 | Roche Diagnostics GmbH | Prediction of postpartum hellp syndrome, postpartum eclampsia or postpartum preeclampsia |
| US11383015B2 (en) * | 2016-01-11 | 2022-07-12 | Fenwal, Inc. | System and method for plasma purification prior to mononuclear cell collection |
| CN108883193A (zh) | 2016-03-31 | 2018-11-23 | 伊穆特丽克斯治疗股份有限公司 | 先兆子痫和有关障碍的体外治疗方法 |
| WO2019026870A1 (ja) * | 2017-08-01 | 2019-02-07 | 学校法人学文館 | ｓＦｌｔ－１（可溶型血管内皮増殖因子受容体－１）の新規測定法 |
| US20200264188A1 (en) * | 2017-09-13 | 2020-08-20 | Progenity, Inc. | Preeclampsia biomarkers and related systems and methods |
| US20190247560A1 (en) | 2018-02-13 | 2019-08-15 | Gambro Lundia Ab | Extracorporeal devices and methods of treating complement factor related diseases |
| WO2020061590A1 (en) * | 2018-09-21 | 2020-03-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for evaluation of gestational progress and preterm abortion for clinical intervention and applications thereof |
| EP3669888B1 (en) | 2018-12-20 | 2025-09-24 | Gambro Lundia AB | Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies |
| JP7526737B2 (ja) | 2019-03-06 | 2024-08-01 | ガンブロ ルンディア アクティエボラーグ | アルカリホスファターゼを含む血液処理装置 |
| EP4070113A4 (en) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | ASSESSMENT OF PREECLAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR TESTS |
| US12426782B2 (en) | 2020-11-06 | 2025-09-30 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and temporal alignment methods for evaluation of gestational age and time to delivery |
| WO2024232421A1 (ja) | 2023-05-11 | 2024-11-14 | タグシクス・バイオ株式会社 | 可溶性ｆｌｔ－１に選択的に結合するｄｎａアプタマーおよびそのｄｎａアプタマーが固定化された担体 |
| WO2025240713A1 (en) * | 2024-05-17 | 2025-11-20 | Aslam Shakil | Method for treating pre-eclampsia with stationary phase heparin |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5240848A (en) | 1988-11-21 | 1993-08-31 | Monsanto Company | Dna sequences encoding human vascular permeability factor having 189 amino acids |
| US4994161A (en) * | 1989-02-02 | 1991-02-19 | University Of New Hampshire | Apparatus and method for macromolecular charge determination |
| US5332671A (en) | 1989-05-12 | 1994-07-26 | Genetech, Inc. | Production of vascular endothelial cell growth factor and DNA encoding same |
| US5194596A (en) | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5219739A (en) | 1989-07-27 | 1993-06-15 | Scios Nova Inc. | DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121 |
| AU4410296A (en) | 1994-11-29 | 1996-06-19 | Duke University | Diagnosis of and therapy for hereditary haemorrhagic telangiectasia |
| EP1016726A1 (en) | 1998-12-30 | 2000-07-05 | Introgene B.V. | Gene therapy to promote angiogenesis |
| DE10117043A1 (de) | 2001-04-05 | 2002-11-07 | Gerhard Puetz | Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen |
| US7435419B2 (en) | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| US7335362B2 (en) | 2002-07-19 | 2008-02-26 | Beth Israel Deaconess Medical Center | Methods of treating pre-eclampsia or eclampsia |
| ES2534926T3 (es) | 2002-07-19 | 2015-04-30 | Beth Israel Deaconess Medical Center | Métodos para tratar la preeclampsia |
| WO2005107802A2 (en) * | 2004-04-30 | 2005-11-17 | Biopheresis Technologies, Llc | Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| SG155257A1 (en) | 2004-09-24 | 2009-09-30 | Beth Israel Hospital | Methods of diagnosing and treating complications of pregnancy |
| US7740849B2 (en) | 2004-09-24 | 2010-06-22 | Beth Israel Deaconess Medical Center | Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders |
| US20060067931A1 (en) | 2004-09-25 | 2006-03-30 | Hazel Lum | Receptor for lysophosphatidylcholine in vascular endothelial cells and use thereof |
| EP1839056B1 (en) * | 2004-12-21 | 2011-08-03 | Yale University | Diagnosis of preeclampsia |
| US20060153835A1 (en) * | 2005-01-12 | 2006-07-13 | Smith Henry J | Treatment of pre-eclampsia in pregnant women using targeted apheresis |
| MX2008015197A (es) | 2006-05-31 | 2009-06-23 | Beth Israel Hospital | Metodos de diagnosticar y tratar las complicaciones del embrazo. |
| US20090286271A1 (en) | 2006-05-31 | 2009-11-19 | Karumanchi Ananth S | Methods of Diagnosing and Treating Complications of Pregnancy |
| PH12012500781A1 (en) * | 2009-11-09 | 2015-03-04 | Zeiss Carl Vision Int Gmbh | Ophthalmic lens element |
| AU2011252954B2 (en) | 2010-05-14 | 2015-04-16 | Beth Israel Deaconess Medical Center | Extracorporeal devices and methods of treating complications of pregnancy |
-
2011
- 2011-05-13 AU AU2011252954A patent/AU2011252954B2/en active Active
- 2011-05-13 WO PCT/US2011/036409 patent/WO2011143538A1/en not_active Ceased
- 2011-05-13 EP EP17176640.5A patent/EP3248946B1/en active Active
- 2011-05-13 US US13/107,198 patent/US8969322B2/en active Active
- 2011-05-13 JP JP2013510331A patent/JP5959506B2/ja active Active
- 2011-05-13 EP EP11781339.4A patent/EP2569253A4/en not_active Withdrawn
- 2011-05-13 EP EP13005691.4A patent/EP2706041B1/en active Active
- 2011-05-13 CA CA2799227A patent/CA2799227C/en active Active
- 2011-05-13 CN CN201180022894.9A patent/CN102884006B/zh active Active
-
2015
- 2015-01-20 US US14/600,912 patent/US9925211B2/en active Active
-
2016
- 2016-02-22 JP JP2016030745A patent/JP2016147065A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532129A5 (https=) | ||
| JP5959506B2 (ja) | 妊娠合併症を治療するための体外デバイスおよび方法 | |
| Honore et al. | Cytokine removal in human septic shock: where are we and where are we going? | |
| Zhang et al. | Myoglobin clearance by continuous venous-venous haemofiltration in rhabdomyolysis with acute kidney injury: a case series | |
| Staff et al. | Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia | |
| Schrey-Petersen et al. | Anti-angiogenesis and Preeclampsia in 2016 | |
| Miao et al. | Clinical benefits of high-volume hemofiltration in critically ill pediatric patients with severe sepsis: a retrospective cohort study | |
| Behrens et al. | Extracellular vesicles as regulators of kidney function and disease | |
| JP2015526725A5 (https=) | ||
| Chen et al. | Free p-cresol sulfate is associated with survival and function of vascular access in chronic hemodialysis patients | |
| Fujioka et al. | Efficiency of leukocyte depletion filters and micro-aggregate filters following intra-operative cell salvage during cesarean delivery | |
| Roohi et al. | Moderately elevated homocysteine does not contribute to thoracic aortic aneurysm in mice | |
| Tanhehco et al. | Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis | |
| Kusztal et al. | Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis (HD) patients | |
| HK1189566A (en) | Extracorporeal devices and methods of treating complications of pregnancy | |
| Guo et al. | Calcitriol ameliorates the progression of hepatic fibrosis through autophagy-related gene 16-like 1-mediated autophagy | |
| Koca et al. | EVALUATİON OF THE EFFECT OF SOLUBLE FMS-LİKE TYROSİNE KİNASE-1 AND BİOCHEMİCAL PARAMETER LEVELS ON PROGNOSİS BEFORE AND AFTER PLASMAPHERESİS İN PREGNANT WOMEN WİTH PREECLAMPSİA | |
| Ali et al. | The effect of pentoxifylline on the glomerular function in patients with severe pre-eclampsia. | |
| Park et al. | Nephroprevention in acute phosphate nephropathy | |
| Habal et al. | The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions | |
| Isermann et al. | CD39 abrogates platelet-derived factors induced IL-1β expression in the human placenta | |
| CN103830263A (zh) | 解聚海参糖胺聚糖在制药中的应用 | |
| CN104147040A (zh) | 海参糖胺聚糖在制备防治血栓栓塞疾病药物中的应用 | |
| Seghers et al. | Research Article A New Method for the Measurement of International Normalized Ratio in Hemodialysis Patients with Heparin-Locked Tunneled Dialysis Catheters | |
| Drenjančević et al. | THE EFFECTS OF AT1 RECEPTOR ANTAGONISM ON ENDOTHELIAL FUNCTION, AND ENDOTHELIAL CELL ADHESION MOLECULES AND THEIR LIGANDS EXPRESSION IN HYPERTENSIVE PATIENTS |